Immediate damage to the blood-spinal cord barrier due to mechanical trauma

Journal of Neurotrauma

Volumn 24, Issue 3, 2007, Pages 492-507

  Maikos, Jason T ^a   Shreiber, David I ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Biomechanics; Blood spinal cord barrier; Hemorrhage; Spinal cord injury

Indexed keywords

HYDRAZIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BLOOD; BLOOD SPINAL CORD BARRIER; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRAVASATION; FEMALE; GRAY MATTER; IMMUNOHISTOCHEMISTRY; NONHUMAN; RAT; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; THORACIC SPINAL CORD; WHITE MATTER;

ALBUMINS; ANIMALS; BRAIN; CAPILLARY PERMEABILITY; ERYTHROCYTES; FEMALE; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NERVE TISSUE PROTEINS; RATS; RATS, LONG-EVANS; SPINAL CORD; SPINAL CORD INJURIES;

EID: 34247126976     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.0149     Document Type: Article

References (57)

1. AMAR, A.P., and LEVY, M.L. (1999). Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44, 1027-1040.
2. ANDERSON, A.J., ROBERT, S., HUANG, W., YOUNG, W., and COTMAN, C. W. (2004). Activation of complement pathways after contusion-induced spinal cord injury. J. Neurotrauma 21, 1831-1846.
3. ARBOGAST, K.B., and MARGULIES, S.S. (1998). Material characterization of the brainstem from oscillatory shear tests. J. Biomech. 31, 801-807.
4. BALENTINE, J.D. (1978). Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab. Invest. 39, 236-253.
5. BAO, F., DEKABAN, G.A., and WEAVER, L.C. (2005). Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J. Neurochem. 94, 1361-1373.
6. BAPTISTE, D.C., and FEHLINGS, M.G. (2006). Pharmacological approaches to repair the injured spinal cord. J. Neurotrauma 23, 318-334.
7. BASSO, D.M., BEATTIE, M.S., and BRESNAHAN, J.C. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
8. BEGGS, J.L., and WAGGENER, J.D. (1975). Vasogenic edema in the injured spinal cord: a method of evaluating the extent of blood-brain barrier alteration to horseradish peroxidase. Exp. Neurol. 49, 86-96.
9. BEGGS, J.L., and WAGGENER, J.D. (1976). Transendothelial vesicular transport of protein following compression injury to the spinal cord. Lab. Invest. 34, 428-439.
10. BERKOWITZ, E.D. (1998). Revealing America's welfare state. [Review of: Howard, C., The hidden welfare state: tax expenditures and social policy in the United States. Princeton University Press, 1997]. Rev. Am. Hist. 26, 620-624.
11. BILGEN, M., and NARAYANA, P.A. (2001). A pharmacokinetic model for quantitative evaluation of spinal cord injury with dynamic contrast-enhanced magnetic resonance irriaging. Magn. Reson. Med. 46, 1099-1106.
12. BILSTON, L.E., LIU, Z., and PHAN-THJEN, N. (2001). Large strain behaviour of brain tissue in shear: some experimental data and differential constitutive model. Biorheology 38, 335-345.
13. BLIGHT, A.R. (1992). Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9, Suppl 1, S83-S91.
14. BORGENS, R.B., and SHI, R. (2000). Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. FASEB J. 14, 27-35.
15. BOTTI, R.E., TRISCARI, J., PAN, H.Y., and ZAYAT, J. (1991). Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin. Neuropharmacol. 14, 256-261.
16. BRESNAHAN, J.C., BEATTIE, M.S., TODD, F.D., 3RD, and NOYES, D.H. (1987). A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp. Neurol. 95, 548-570.
17. DEMJEN, D., KLUSSMANN, S., KLEBER, S., et al. (2004). Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat. Med. 10, 389-395.
18. DOHRMANN, G.J., PANJABI, M.M., and WAGNER, F.C., JR. (1976). An apparatus for quantitating experimental spinal cord trauma. Surg. Neurol. 5, 315-318.
19. DOHRMANN, G.J., and WICK, K.M. (1971). Demonstration of the microvasculature of the spinal cord by intravenous injection of the fluorescent dye, thioflavine S. Stain Technol. 46, 321-322.
20. FADEN, A.I., GANNON, A., and BASBAUM, A.I. (1988). Use of serotonin immunocytochemistry as a marker of injury severity after experimental spinal trauma in rats. Brain Res. 450, 94-100.
21. FAROOQUE, M., ZHANG, Y., HOLTZ, A., and OLSSON, Y. (1992). Exudation of fibronectin and albumin after spinal cord injury in rats. Acta Neuropathol. (Berl.) 84, 613-620.
22. FEHLINGS, M.G., and TATOR, C.H. (1995). The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132, 220-228.
23. GRIFFITHS, I.R., and MILLER, R. (1974). Vascular permeability to protein and vasogenic oedema in experimental concussive injuries to the canine spinal cord. J. Neurol. Sci. 22, 291-304.
24. HERNANDEZ, L.A., GRISHAM, M.B., TWOHIG, B., ARFORS, K.E., HARLAN, J.M. and GRANGER, D.N. (1987). Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol. 253, H699-H703.
25. JAEGER, C.B., and BLIGHT, A.R. (1997). Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after bloodbrain barrier breakdown and repair. Exp. Neurol. 144, 381-399.
26. MAUTES, A.E., WEINZIERL, M.R., DONOVAN, F., and NOBLE, L.J. (2000). Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys. Ther. 80, 673-687.
27. McKENZIE, A.L., HALL, J.J., AIHARA, N., FUKUDA, K., and NOBLE, L.J. (1995). Immunolocalization of endothelin in the traumatized spinal cord: relationship to blood-spinal cord barrier breakdown. J. Neurotrauma 12, 257-268.
28. MOORADIAN, A.D., HAAS, M.J., BATEJKO, O., HOVSEPYAN, M., and FEMAN, S. S. (2005). Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes 54, 2977-2982.
29. NOBLE, L.J., MAUTES, A.E., and HALL, J.J. (1996). Characterization of the microvascular glycocalyx in normal and injured spinal cord in the rat. J. Comp. Neurol. 376, 542-556.
30. NOBLE, L.J., and MAXWELL, D.S. (1983). Blood-spinal cord barrier response to transection. Exp. Neurol. 79, 188-199.
31. NOBLE, L.J., and WRATHALL, J.R. (1985). Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp. Neurol. 88, 135-149.
32. NOBLE, L.J., and WRATHALL, J.R. (1987). The blood-spinal cord barrier after injury: pattern of vascular events proximal and distal to a transection in the rat. Brain Res. 424, 177-188.
33. NOBLE, L.J., and WRATHALL, J.R. (1989a). Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp. Neurol. 103, 34-40.
34. NOBLE, L.J., and WRATHALL, J.R. (1989b). Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res. 482, 57-66.
35. NOYES, D.H. (1987). Electromechanical impactor for producing experimental spinal cord injury in animals. Med. Biol. Eng. Comput. 25, 335-340.
36. PAN, W., BANKS, W.A., and KASTIN, A.J. (1997). Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp. Neurol. 146, 367-373.
37. PAN, W., ZHANG, L., LIAO, J., CSERNUS, B., and KASTIN, A.J. (2003). Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI. J. Neuroimmunol. 134, 111-117.
38. PANNU, R., BARBOSA, E., SINGH, A.K., and SINGH, I. (2005). Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J. Neurosci. Res. 79, 340-350.
39. POPOVICH, P.G., HORNER, P.J., MULLIN, B.B., and STOKES, B.T. (1996). A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 142, 258-275.
40. POPOVICH, P.G., REINHARD, J.F., JR., FLANAGAN, E.M., and STOKES, B.T. (1994). Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma. Brain Res. 633, 348-352.
41. POPOVICH, P.G., WEI, P., and STOKES, B.T. (1997). Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377, 443-464.
42. PRANGE, M.T., and MARGULIES, S.S. (2002). Regional, directional, and age-dependent properties of the brain undergoing large deformation. J. Biomech. Eng. 124, 244-252.
43. SAVILLE, L.R., POSPISIL, C.H., MAWHINNEY, L.A., et al. (2004). A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J. Neuroimmunol. 156, 42-57.
44. SHARMA, H.S. (2005). Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr. Pharm. Des. 11, 1353-1389.
45. SHI, L., TANG, G.P., GAO, S.J., et al. (2003). Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther. 10, 1179-1188.
46. SPARKS, D.L., CONNOR, D.J., BROWNE, P.J., LOPEZ, J.E., and SABBAGH, M.N. (2002). HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J. Nutr. Health Aging 6, 324-331.
47. STANISLAUS, R., PAHAN, K., SINGH, A.K., and SINGH, I. (1999). Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci. Lett. 269, 71-74.
48. STANISLAUS, R., SINGH, A.K., and SINGH, I. (2001). Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 66, 155-162.
49. STEWART, W.W. (1981). Lucifer dyes-highly fluorescent dyes for biological tracing. Nature 292, 17-21.
50. STOKES, B.T., NOYES, D.H., and BEHRMANN, D.L. (1992). An electromechanical spinal injury technique with dynamic sensitivity. J. Neurotrauma 9, 187-195.
51. SUGIO, S., KASHIMA, A., MOCHIZUKI, S., NODA, M., and KOBAYASHI, K. (1999). Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 12, 439-446.
52. TERAE, S., TAKAHASHI, C., ABE, S., KIKUCHI, Y., and MIYASAKA, K. (1997). Gd-DTPA-enhanced MR imaging of injured spinal cord. Clin. Imaging 21, 82-89.
53. UNGER, E.C., PORTER, T., CULP, W., LABELL, R., MATSUNAGA, T., and ZUTSHI, R. (2004). Therapeutic applications of lipid-coated microbubbles. Adv. Drug Deliv. Rev. 56, 1291-1314.
54. WAGNER, F.C., JR., and STEWART, W.B. (1981). Effect of trauma dose on spinal cord edema. J. Neurosurg. 54, 802-806.
55. WESTMARK, R., NOBLE, L.J., FUKUDA, K., AIHARA, N., and McKENZIE, A.L. (1995). Intrathecal administration of endothelin-1 in the rat: impact on spinal cord blood flow and the blood-spinal cord barrier. Neurosci. Lett. 192, 173-176.
56. WHETSTONE, W.D., HSU, J.Y., EISENBERG, M., WERB, Z., and NOBLE-HAEUSSLEIN, L.J. (2003). Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing. J. Neurosci. Res. 74, 227-239.
57. YOUNG, W. (2002). Spinal cord contusion models. Prog. Brain Res. 137, 231-255.